WealthTrust Axiom’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
61,500
-2,000
| -3% | -$10.9K | 0.1% | 172 |
|
|
2025
Q1 | $399K | Sell |
63,500
-2,000
| -3% | -$12.6K | 0.12% | 155 |
|
|
2024
Q4 | $270K | Buy |
65,500
+2,000
| +3% | +$8.24K | 0.08% | 193 |
|
|
2024
Q3 | $212K | Hold |
63,500
| – | – | 0.06% | 230 |
|
|
2024
Q2 | $189K | Hold |
63,500
| – | – | 0.06% | 226 |
|
|
2024
Q1 | $219K | Hold |
63,500
| – | – | 0.07% | 219 |
|
|
2023
Q4 | $85.1K | Sell |
63,500
-30,000
| -32% | -$40.2K | 0.03% | 236 |
|
|
2023
Q3 | $204K | Hold |
93,500
| – | – | 0.07% | 208 |
|
|
2023
Q2 | $223K | Hold |
93,500
| – | – | 0.07% | 211 |
|
|
2023
Q1 | $173K | Hold |
93,500
| – | – | 0.06% | 219 |
|
|
2022
Q4 | $180K | Hold |
93,500
| – | – | 0.06% | 212 |
|
|
2022
Q3 | $143K | Hold |
93,500
| – | – | 0.05% | 216 |
|
|
2022
Q2 | $262K | Sell |
93,500
-5,000
| -5% | -$14K | 0.09% | 179 |
|
|
2022
Q1 | $216K | Buy |
98,500
+70,000
| +246% | +$154K | 0.07% | 217 |
|
|
2021
Q4 | $22K | Sell |
28,500
-8,000
| -22% | -$6.18K | 0.01% | 259 |
|
|
2021
Q3 | $51K | Sell |
36,500
-3,000
| -8% | -$4.19K | 0.02% | 246 |
|
|
2021
Q2 | $88K | Buy |
39,500
+1,000
| +3% | +$2.23K | 0.03% | 249 |
|
|
2021
Q1 | $104K | Buy |
38,500
+27,000
| +235% | +$72.9K | 0.04% | 232 |
|
|
2020
Q4 | $27K | Buy |
+11,500
| New | +$27K | 0.01% | 236 |
|